Specifically, SA binds to PHD2 and inhibits its activity, preventing its interaction with the ODD domain of HIF-1α, thereby enhancing HIF-1α stability and promoting tumor angiogenesis by upregulating VEGFA expression (Figure 8F). Here, EGLN1 is linked to neoplasm.